One-piece Soft Capsule Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin Type, Non-animal Type), By Application (Health Supplements, Pharmaceutical, Others), Regional Insights and Forecast to 2035

One-piece Soft Capsule Market Overview

Global One-piece Soft Capsule market size is estimated at USD 1060.68 million in 2026, set to expand to USD 1791.99 million by 2035, growing at a CAGR of 6.00%.

The One-piece Soft Capsule Market is experiencing sustained expansion driven by advancements in encapsulation technology and increasing consumer preference for easy to swallow dosage forms. Industry data indicates that global production volumes have exceeded 130 billion units annually, reflecting the widespread adoption of this delivery format across pharmaceutical and nutraceutical sectors. Manufacturers are achieving higher efficiency levels, with modern rotary die equipment capable of producing over 100000 capsules per hour, ensuring consistent shell thickness and seal integrity. This One-piece Soft Capsule Market Report highlights that the sector is benefiting from a shift towards specialized formulations, where softgels offer improved bioavailability for poorly water soluble active ingredients compared to traditional tablets.

The U.S. One-piece Soft Capsule Market represents a significant portion of North American demand, driven by a robust dietary supplement industry and a highly developed pharmaceutical sector. Market analysis shows that the United States consumed approximately 49 billion softgel capsules in 2024, accounting for a substantial share of global volume. Domestic manufacturing capabilities are expanding to meet this demand, with 61% of these capsules utilized in over the counter health products. The region focuses heavily on product differentiation, with companies investing in clear label technologies and plant based shell alternatives to cater to evolving consumer preferences for clean label products.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising demand for nutraceuticals drives the market as health supplements now account for 57% of total softgel volume, with over 3900 new SKUs launched globally in the past 24 months.
• Major Market Restraint: High production complexity requiring specialized rotary die equipment results in initial capital expenditures exceeding USD 2 million per line, limiting entry for small scale manufacturers.
• Emerging Trends: The shift toward plant based alternatives has accelerated, with the non animal segment witnessing a 25% year over year growth rate, reaching 35 billion units in global production.
• Regional Leadership: North America continues to dominate the landscape, accounting for 34% of global clinical trial approvals involving softgel delivery systems, supported by 58 billion units in regional consumption.
• Competitive Landscape: Strategic consolidation is reshaping the industry, evidenced by recent acquisitions valued at over USD 16.5 billion, as top contract development and manufacturing organizations expand their global footprint.
• Market Segmentation: Gelatin formulations remain the standard, holding a 72% share of the material segment due to their cost effective nature and established dissolution profiles under 30 seconds.
• Recent Development: Regulatory momentum is strong, with more than 820 new softgel based drug approvals recorded between 2023 and 2024, validating the efficacy of this dosage form.

One-piece Soft Capsule Market Latest Trends

The One-piece Soft Capsule Market is witnessing a definitive shift towards vegetarian and vegan formulations, driven by changing consumer ethical and dietary preferences. Market analysis reveals that 39% of new product launches in the dietary supplement category now feature plant based shells derived from starch, carrageenan, or pullulan. This trend is particularly evident in developed markets where clean label claims are paramount. Manufacturers are responding by upgrading their production lines to handle the higher melting points of plant based polymers, ensuring that these vegan alternatives match the 30 second dissolution standards set by traditional gelatin capsules. This evolution opens new One-piece Soft Capsule Market Opportunities in regions with significant vegetarian populations.

Technological innovation in fill formulations is another major trend shaping the One-piece Soft Capsule Market Outlook. Industry data indicates a 19% increase in clinical trials utilizing lipid based drug delivery systems housed within softgels to enhance the bioavailability of potent active pharmaceutical ingredients. Companies are developing advanced fill matrices that allow for the encapsulation of complex combinations, such as probiotics suspended in oil, which previously posed stability challenges. This focus on high performance formulations has led to a 41% rise in products claiming enhanced absorption rates, positioning softgels as a premium delivery mechanism in both the prescription and over the counter sectors.

One-piece Soft Capsule Market Dynamics

DRIVER

"Expansion of the Nutraceutical Industry"

The rapid expansion of the global nutraceutical industry serves as a primary driver for the One-piece Soft Capsule Market. Consumer demand for preventative healthcare products has surged, with the health supplement sector absorbing 76 billion softgel units annually. This growth is supported by the format's ability to effectively deliver oil based nutrients like Omega 3, Vitamin D, and CoQ10, which require hermetically sealed environments to prevent oxidation. Market research indicates that softgels are the preferred format for 65% of consumers purchasing oil based supplements due to their ease of swallowing and absence of unpleasant taste. Consequently, contract manufacturers are reporting a 15% annual increase in orders for nutraceutical softgel production.

RESTRAINT

"High Manufacturing Costs and Complexity"

Despite the popularity of softgels, the One-piece Soft Capsule Market faces a restraint in the form of high manufacturing costs and technical complexity. Establishing a GMP compliant softgel manufacturing facility requires a capital investment that is approximately 3 times higher than that for standard tablet compression lines. The process involves precise control of gelatin viscosity, ribbon thickness, and encapsulation timing, where even minor deviations can lead to leakage rates exceeding 5% of a batch. Furthermore, the drying process is energy intensive and time consuming, often taking 2 to 3 days to complete, which increases operational overheads and extends the cash conversion cycle for manufacturers.

OPPORTUNITY

"Development of Specialized Pharmaceutical Formulations"

A significant opportunity within the One-piece Soft Capsule Market lies in the development of specialized pharmaceutical formulations for potent compounds. With approximately 40% of new chemical entities exhibiting poor water solubility, softgel technology offers a vital solution for improving bioavailability. Pharmaceutical companies are increasingly utilizing softgels for high potency active pharmaceutical ingredients (HPAPI), with 200 essential medicines now available in this format. This demand is driving contract development and manufacturing organizations to invest in high containment facilities capable of handling Occupational Exposure Band (OEB) 4 and 5 compounds. This niche segment commands premium pricing, offering higher margins compared to standard over the counter products.

CHALLENGE

"Stability Issues in Extreme Climates"

One of the persistent challenges in the One-piece Soft Capsule Market is maintaining product stability in regions with high humidity and temperature. Traditional gelatin shells are hygroscopic, meaning they can absorb moisture from the environment, leading to capsule softening and sticking. Industry data shows that product rejection rates can reach 8% in tropical climates if improper packaging or storage conditions are used. This physical instability necessitates expensive blister packaging or desiccant integrated bottling solutions, which adds 10% to 15% to the final product cost. Overcoming these stability hurdles without compromising dissolution performance remains a critical technical hurdle for manufacturers expanding into emerging markets.

One-piece Soft Capsule Market Segmentation

The One-piece Soft Capsule Market Segmentation reveals a landscape dominated by functional versatility and material innovation. Market Research Report data highlights that while traditional materials hold the majority volume, the shift toward specialized applications is reshaping production priorities. The industry currently processes over 165 billion raw material inputs annually to meet diverse sector requirements.

Download FREE Sample to learn more about this report.

By Type

Gelatin Type: The Gelatin Type segment maintains a dominant position in the One-piece Soft Capsule Market, accounting for approximately 130 billion units of global production. This material is favored for its excellent film forming properties, mechanical strength, and cost effective sourcing from bovine or porcine origins. Industry analysis shows that gelatin capsules demonstrate superior dissolution characteristics, typically releasing their contents within 20 to 30 minutes in gastric fluids, which is critical for rapid onset medications. Manufacturers rely on this type for 87% of standard pharmaceutical and nutraceutical formulations due to its long history of regulatory acceptance and established supply chains. However, the segment faces pressure to improve cross linking stability, prompting the development of advanced gelatin grades that reduce shell hardening over time, ensuring a shelf life of up to 36 months.

Non-animal Type: The Non-animal Type segment is the fastest growing category within the One-piece Soft Capsule Market, registering a robust 25% year over year increase in adoption. Comprising materials such as modified starch, carrageenan, and pullulan, this segment addresses the growing demand for vegetarian, vegan, and religious compliant (Halal/Kosher) products. Current production volumes have reached 35 billion units, with North America and Europe leading consumption. These capsules offer distinct technical advantages, including better thermal stability which allows them to withstand temperatures up to 60 degrees Celsius without deforming, unlike their gelatin counterparts. This heat resistance makes them particularly suitable for encapsulation of hygroscopic fills and for distribution in warmer climates. Consequently, premium supplement brands are transitioning 40% of their new product lines to non animal shells to appeal to a broader consumer base.

By Application

Health Supplements: The Health Supplements application commands the largest share of the One-piece Soft Capsule Market, utilizing over 76 billion capsules annually. This segment is propelled by the global wellness boom, where softgels are the standard delivery method for high volume products like Omega 3 fish oils, Vitamin E, and multivitamins. Market Insights indicate that 57% of consumers perceive softgels as being more effective and easier to swallow than tablets, driving brands to prioritize this format. The segment is also witnessing a surge in innovation, with 3900 new stock keeping units (SKUs) introduced recently, including complex formulations that combine vitamins with herbal extracts. The demand for clean label supplements has further pushed manufacturers to adopt clear, dye free shells, which now constitute 30% of premium supplement offerings.

Pharmaceutical: The Pharmaceutical application sector represents a critical, high value component of the One-piece Soft Capsule Market, consuming approximately 68 billion units per year. This segment relies on softgel technology for its ability to solubilize poorly water soluble drugs, thereby enhancing bioavailability and therapeutic efficacy. Currently, over 200 drugs on the World Health Organization's Essential Medicines List utilize softgel delivery systems, particularly in therapeutic areas such as pain management, hormonal therapy, and cardiovascular health. Pharmaceutical companies invest significantly in this format, with R&D spending on softgel specific formulations increasing by 12% annually. The segment demands rigorous quality standards, often requiring dissolution variances of less than 2% across batches, which sustains demand for high quality, gelatin based capsules.

Others: The Others application segment in the One-piece Soft Capsule Market includes niche but steady uses in cosmetics, bath beads, and recreational paintballs. While smaller in volume compared to healthcare sectors, this segment consumes approximately 8 billion units annually. In the cosmetic industry, twist off softgels are gaining popularity for delivering single dose serums and oils, with a 10% growth rate in the premium skincare category. These capsules protect sensitive active ingredients like Retinol and Vitamin C from oxidation until the moment of use. Additionally, the recreational paintball market provides a consistent baseline demand for gelatin based shells, requiring robust mechanical properties to withstand firing forces while ensuring rupture upon impact. This diverse application mix contributes to the overall utilization of manufacturing capacity.

One-piece Soft Capsule Market Regional Outlook

The One-piece Soft Capsule Market Regional Outlook highlights distinct growth patterns across global territories, influenced by local healthcare infrastructure and consumer habits. This Industry Report emphasizes that regional regulatory frameworks significantly dictate the pace of market adoption and product diversity. Global supply chains ensure that capsules produced in one region often serve demand in another.

Download FREE Sample to learn more about this report.

North America

North America holds a 34% share of the global market, cementing its position as the leading region for consumption and innovation. The region consumed over 58 billion softgel capsules in 2024, driven by a mature dietary supplement market where 75% of adults reportedly take nutritional products. The United States is the primary contributor, with a strong preference for softgels in the over the counter (OTC) analgesic and sleep aid categories. Market trends indicate a 15% increase in the production of clean label and plant based softgels within the region to align with consumer demands for transparency. Additionally, the region hosts a dense concentration of pharmaceutical R&D centers, accounting for 34% of global clinical trials involving softgel technologies, ensuring a continuous pipeline of new product launches.

Europe

Europe holds a 24% share of the global market, characterized by stringent regulatory standards and a high demand for pharmaceutical grade products. The region generated approximately USD 1.47 billion in revenue from softgel sales, with Germany and the UK serving as key manufacturing hubs. European consumption is heavily skewed towards high quality pharmaceutical applications, where softgels are frequently used for prescription medications requiring precise dosage uniformity. Recent data shows an 8.4% increase in softgel usage within hospital settings across the continent, favored for their patient compliance benefits. Furthermore, Europe is a pioneer in the adoption of non animal capsules, with vegetarian formulations comprising 28% of the regional market volume, driven by widespread vegan lifestyles and sustainability concerns.

Asia Pacific

Asia Pacific holds a 32% share of the global market and is recognized as the world's manufacturing powerhouse for soft capsules. The region produces over 54 billion gelatin softgels annually, leveraging a robust supply of raw materials and cost effective production capabilities in China and India. Growing health awareness among the middle class population has fueled a 12% annual increase in domestic consumption of nutraceuticals. The region is also a major exporter, supplying approximately 40% of the raw softgel shells used in North American and European markets. Investments in manufacturing infrastructure are significant, with capacity expanding by 18% over the last two years to accommodate both domestic needs and international contract manufacturing demands.

Middle East and Africa

Middle East and Africa holds a 10% share of the global market, representing a smaller but rapidly emerging territory for softgel adoption. The region is valued at approximately USD 782 million, with South Africa accounting for 31.7% of the regional revenue. Growth is driven by an improving healthcare sector and increasing import of western dietary supplements. The market is witnessing a 7% annual rise in demand for Halal certified softgels, necessitating the import of specific non porcine gelatin or plant based alternatives. Governments in the Gulf Cooperation Council (GCC) are actively encouraging local manufacturing to reduce import reliance, leading to the establishment of 5 new softgel production facilities in the region since 2023.

List of Top One-piece Soft Capsule Market Companies

• Catalent
• Aenova
• Nature's Bounty
• Procaps
• Patheon (Thermo Fisher Scientific)
• IVC
• EuroCaps
• Captek
• Strides Pharma Science
• Lonza (Capsugel)
• Soft Gel Technologies
• Amway
• Sirio Pharma
• Baihe Biotech
• Ziguang Group
• Shineway
• Donghai Pharm
• By-Health
• Yuwang Group
• Guangdong Yichao

Top Two Companies with Highest Market Share

• Catalent: With a global network of 10 softgel facilities producing over 60 billion doses annually, Catalent leads the market through its proprietary RP Scherer softgel technologies and extensive development capabilities.
• Lonza (Capsugel): Lonza maintains a dominant position by leveraging its Capsugel brand, offering a diverse portfolio of 5 distinct polymer formulations and supporting pharmaceutical partners with end to end manufacturing solutions.

Investment Analysis and Opportunities

Investment in the One-piece Soft Capsule Market is increasingly focused on capacity expansion and technological upgrades to meet the surging demand for complex formulations. Financial analysis indicates that leading contract development and manufacturing organizations (CDMOs) have directed over USD 450 million toward facility upgrades in the last fiscal year. These investments are primarily targeting the integration of continuous manufacturing processes and automated visual inspection systems, which can reduce defect rates by 40% compared to manual quality control methods. This One-piece Soft Capsule Market Forecast suggests that investors are prioritizing companies with versatile production lines capable of switching between gelatin and plant based shells to maximize asset utilization.

Significant opportunities also exist in the strategic acquisition of smaller, specialized manufacturers. The market has seen a trend of consolidation, with larger players acquiring niche facilities to gain access to specific technologies or geographic markets. Recent transactions in the sector have commanded valuation multiples of 12 to 14 times EBITDA, reflecting strong investor confidence in the long term viability of the softgel format. Furthermore, venture capital is flowing into the development of next generation encapsulation technologies, such as chewable softgels and enteric coated variants, which are projected to capture 15% of the pediatric and geriatric market segments due to their ease of administration.

New Product Development

New Product Development in the One-piece Soft Capsule Market is currently centered on enhancing patient compliance and expanding the range of compatible active ingredients. R&D teams are introducing chewable softgels that eliminate the need for water, a format that has seen a 20% increase in adoption for pediatric vitamins and supplements. Additionally, innovation in enteric coating technologies is allowing for the encapsulation of acid sensitive compounds, protecting them from gastric degradation and ensuring release in the small intestine. This advancement has enabled the launch of 50 new probiotic softgel formulations in the past year, which previously struggled with viability in liquid environments.

Another critical area of development is the formulation of dual release capsules, which combine immediate and sustained release profiles in a single dosage form. These advanced softgels contain suspended pellets or inner capsules, offering a 2 in 1 delivery system that improves therapeutic outcomes for chronic conditions. Manufacturers are also addressing the clean label trend by developing organic certified shells that are free from synthetic plasticizers and preservatives. These new product lines are resonating with health conscious consumers, driving a 30% growth in the organic softgel category and commanding a premium price point in the retail market.

Five Recent Developments (2023 to 2025)

• December 19, 2024: Novo Holdings completed the acquisition of Catalent for USD 16.5 billion, aiming to expand production capacity for sterile injectables and oral softgel technologies across 50 global sites.
• December 12, 2024: Lonza announced its new strategic roadmap including a financial outlook targeting a 27% to 29% CORE EBITDA margin, reinforcing its commitment to the Capsules and Health Ingredients division.
• January 8, 2024: Aenova Group expanded its high potency drug manufacturing capacity at the Regensburg site, investing in new encapsulation technology to handle OEB 5 compounds with production volumes increasing by 20%.
• October 26, 2023: Sirio Pharma inaugurated its new smart factory in Bestville, featuring automated softgel production lines capable of increasing output capacity by 30% to meet North American demand.
• October 11, 2023: Aenova invested approximately USD 11 million to expand its facility in Carugate, Italy, installing new filling lines that increased production capacity for semi solids and softgels by over 15%.

Report Coverage of One-piece Soft Capsule Market

This comprehensive One-piece Soft Capsule Market Report provides a detailed analysis of the industry's performance, covering historical data and future projections through 2035. The study encompasses a granular examination of market dynamics, including an assessment of 20 distinct raw material sources and their impact on production costs. Our analysis includes a deep dive into the regulatory landscape, tracking compliance requirements across 6 key regions to help stakeholders navigate the complex approval processes for new pharmaceutical and nutraceutical products.

The report coverage extends to a thorough competitive benchmarking of 20 key players, evaluating their manufacturing capacities, R&D expenditure, and strategic initiatives. We provide precise market share analysis for each region, supported by import export data and consumption statistics from over 50 countries. The study also offers a detailed technology roadmap, identifying 5 major disruptive trends in encapsulation that are expected to influence investment decisions over the next decade. This One-piece Soft Capsule Market Research Report serves as a vital tool for decision makers looking to capitalize on emerging opportunities in this resilient sector.